Cambricon
688256
Ping An Insurance
601318
China Vanke Co.,Ltd.
000002
4
Kweichow Moutai
600519
5
Semiconductor Manufacturing International Corporation
688981
CN Stock MarketDetailed Quotes
600161 Beijing Tiantan Biological Products Corporation
- 20.93
- +0.28+1.36%
Not Open Jan 23 15:00 CST
41.39BMarket Cap32.50P/E (TTM)
21.14High20.64Low165.40KlotVolume20.81Open20.65Pre Close345.67MTurnover0.84%Turnover Ratio37.31P/E (Static)1.98BShares27.6052wk High3.89P/B41.39BFloat Cap18.8852wk Low22.72Limit Up1.98BShs Float36.84Historical High18.59Limit Down2.42%Amplitude-0.04Historical Low0.13Dividend TTM20.90Avg Price74.16KlotAsk0.60%Div YieldTTM100Lot Size86.61KlotBid
Beijing Tiantan Biological Products Corporation Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 1.28%4.07B | 5.59%2.84B | -5.42%1.22B | 21.57%5.18B | 38.09%4.02B | 42.34%2.69B | 83.30%1.29B | 3.63%4.26B | 3.36%2.91B | 4.37%1.89B |
| Operating revenue | 1.28%4.07B | 5.59%2.84B | -5.42%1.22B | 21.57%5.18B | 38.09%4.02B | 42.34%2.69B | 83.30%1.29B | 3.63%4.26B | 3.36%2.91B | 4.37%1.89B |
| Other operating revenue | ---- | 23.82%10.55M | ---- | 9.03%18.38M | ---- | 6.95%8.52M | ---- | 15.10%16.86M | ---- | 32.89%7.97M |
| Total operating cost | -8.42%2.4B | -5.80%1.68B | -18.18%722.8M | 17.99%3.43B | 31.43%2.62B | 37.71%1.78B | 70.55%883.4M | 1.17%2.91B | 4.79%1.99B | 4.20%1.3B |
| Operating cost | -10.22%1.82B | -9.05%1.26B | -23.07%536.72M | 17.54%2.55B | 35.70%2.03B | 43.02%1.38B | 91.57%697.68M | 0.57%2.17B | 3.43%1.49B | 2.70%968.32M |
| Operating tax surcharges | 6.52%41.58M | 10.27%29.19M | 10.16%12.3M | 8.29%48.64M | 36.82%39.04M | 40.61%26.47M | 29.51%11.16M | -4.57%44.92M | -9.60%28.53M | -10.54%18.83M |
| Operating expense | -39.71%119.81M | -27.59%110.75M | -19.97%55.53M | 3.22%270.52M | 0.41%198.71M | 19.82%152.95M | 13.52%69.38M | -3.22%262.08M | 2.91%197.89M | 5.21%127.66M |
| Administration expense | 5.76%348.45M | 9.43%235.88M | 6.24%108.23M | 28.36%469.46M | 40.11%329.48M | 39.69%215.55M | 31.09%101.88M | 11.30%365.75M | 10.97%235.16M | 13.90%154.31M |
| Financial expense | 10.87%-30.25M | -9.36%-23.69M | -130.96%-14.43M | 14.60%-49.53M | 22.91%-33.94M | 31.96%-21.66M | 61.63%-6.25M | 9.60%-57.99M | 10.50%-44.03M | -45.65%-31.84M |
| -Interest expense (Financial expense) | -5.79%3.81M | -4.00%2.55M | -78.57%1.2M | 51.58%3.65M | 143.18%4.05M | 136.25%2.66M | --5.59M | -21.96%2.41M | 27.50%1.66M | -13.74%1.13M |
| -Interest Income (Financial expense) | 8.14%-36.31M | -9.35%-27.74M | -4.27%-12.52M | 10.53%-55.53M | 19.66%-39.53M | 24.82%-25.36M | 29.90%-12.01M | 9.95%-62.06M | 7.41%-49.2M | -35.13%-33.74M |
| Research and development | 69.15%98.7M | 166.36%68.97M | 156.34%24.45M | 14.70%139.95M | -28.07%58.35M | -55.55%25.89M | -57.85%9.54M | -8.40%122.01M | 14.83%81.12M | 30.88%58.25M |
| Credit Impairment Loss | 233.80%1.81M | -248.22%-1.61M | -89.95%87.69K | -596.74%-2.01M | -8,100.13%-1.35M | 24.31%-462.12K | 427.39%872.2K | 76.69%-288.51K | 97.68%-16.46K | -30.18%-610.58K |
| Asset Impairment Loss | -319.76%-1.57M | 203.94%179.85K | -65.36%-243.2K | 3.85%-2.17M | -334.69%-374.76K | -165.42%-173.03K | 27.14%-147.07K | 85.12%-2.25M | 985.80%159.68K | 323.57%264.47K |
| Other net revenue | 32.50%51.15M | 11.07%30.83M | -8.89%17.11M | -30.01%54.32M | -30.48%38.6M | -3.08%27.76M | -5.21%18.78M | 1,198.66%77.6M | 320.01%55.53M | 199.79%28.64M |
| Invest income | 15.65%31.2M | 37.67%23.05M | 21.29%10.23M | 32.31%37.21M | 33.85%26.98M | 45.20%16.74M | 50.00%8.44M | 134.39%28.13M | --20.16M | --11.53M |
| Asset deal income | 1,898.47%37.5K | 1,898.47%37.5K | ---- | -100.33%-51.78K | -100.01%-2.09K | ---2.09K | ---- | 2,952.74%15.63M | 160.80%15.44M | ---- |
| Other revenue | 47.39%19.68M | -21.28%9.17M | -26.88%7.03M | -41.39%21.33M | -32.52%13.35M | -33.24%11.65M | -34.39%9.61M | 269.59%36.4M | 146.51%19.79M | 313.78%17.45M |
| Operating profit | 19.72%1.73B | 27.49%1.19B | 20.80%516.26M | 26.04%1.8B | 47.78%1.44B | 49.85%934.62M | 106.78%427.36M | 15.04%1.43B | 4.95%975.92M | 7.98%623.69M |
| Add:Non operating Income | -77.25%408.97K | -76.80%240.78K | -85.18%102.04K | 80.68%5M | -38.16%1.8M | 215.96%1.04M | 191.00%688.54K | 336.68%2.77M | 732.02%2.91M | 184.88%328.43K |
| Less:Non operating expense | -14.21%2.57M | 140.19%1.44M | 54.41%143.62K | 32.38%11.4M | -36.70%3M | -20.89%598.23K | -79.36%93.02K | 90.39%8.61M | 70.45%4.73M | 23.38%756.23K |
| Total profit | 19.66%1.72B | 27.30%1.19B | 20.63%516.22M | 26.10%1.8B | 47.94%1.44B | 50.03%935.06M | 107.28%427.95M | 14.93%1.43B | 5.03%974.09M | 8.00%623.27M |
| Less:Income tax cost | 27.25%297.04M | 27.39%204.91M | 21.93%84.1M | 30.48%289.14M | 57.52%233.44M | 71.11%160.86M | 123.19%68.97M | 28.68%221.6M | 8.02%148.19M | 6.75%94.01M |
| Net profit | 18.20%1.43B | 27.29%985.46M | 20.38%432.13M | 25.30%1.51B | 46.22%1.21B | 46.28%774.2M | 104.49%358.98M | 12.71%1.2B | 4.51%825.9M | 8.23%529.26M |
| Net profit from continuing operation | 18.20%1.43B | 27.29%985.46M | 20.38%432.13M | 25.30%1.51B | 46.22%1.21B | 46.28%774.2M | 104.49%358.98M | 12.71%1.2B | 4.51%825.9M | 8.23%529.26M |
| Less:Minority Profit | 17.32%375.67M | 25.06%259.37M | 18.93%115.45M | 23.42%399.57M | 42.29%320.22M | 43.73%207.4M | 92.69%97.07M | 4.84%323.76M | -3.07%225.04M | -5.15%144.3M |
| Net profit of parent company owners | 18.52%1.05B | 28.10%726.09M | 20.91%316.67M | 25.99%1.11B | 47.69%887.4M | 47.24%566.8M | 109.23%261.91M | 15.91%880.92M | 7.67%600.86M | 14.27%384.95M |
| Earning per share | ||||||||||
| Basic earning per share | 17.78%0.53 | 27.59%0.37 | 18.75%0.19 | 26.42%0.67 | 25.00%0.45 | 26.09%0.29 | 100.00%0.16 | 12.77%0.53 | 2.86%0.36 | 4.55%0.23 |
| Diluted earning per share | 17.78%0.53 | 27.59%0.37 | 18.75%0.19 | 26.42%0.67 | 25.00%0.45 | 26.09%0.29 | 100.00%0.16 | 12.77%0.53 | 2.86%0.36 | 4.55%0.23 |
| Other composite income | 19.1M | 19.1M | ||||||||
| Other composite income of parent company owners | --14.13M | --14.13M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other composite income of minority owners | --4.96M | --4.96M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total composite income | 19.78%1.45B | 29.75%1B | 20.38%432.13M | 25.30%1.51B | 46.22%1.21B | 46.28%774.2M | 104.49%358.98M | 12.71%1.2B | 4.51%825.9M | 8.23%529.26M |
| Total composite income of parent company owners | 20.11%1.07B | 30.60%740.22M | 20.91%316.67M | 25.99%1.11B | 47.69%887.4M | 47.24%566.8M | 109.23%261.91M | 15.91%880.92M | 7.67%600.86M | 14.27%384.95M |
| Total composite income of minority owners | 18.87%380.64M | 27.45%264.33M | 18.93%115.45M | 23.42%399.57M | 42.29%320.22M | 43.73%207.4M | 92.69%97.07M | 4.84%323.76M | -3.07%225.04M | -5.15%144.3M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.